Discover 532 paid clinical trials in Hershey, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 532
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Location: West Reading PA, Danville PA, Lewisburg PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
Safety of Oral Anticoagulants Registry
for
Blood Coagulation
Location: West Reading PA, Brooklyn NY, Hartford CT, Cleveland OH,
Sponsor: Hospital Quality Foundation
Sex: All
Age: 18+
Code: NCT02745054
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Relapsed Diffuse Large B-cell Lymphoma,
Location: West Reading PA, Pittsburgh PA, Greenville NC,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Sex: All
Age: 18+
Code: NCT04920617
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: West Reading PA, Broomall PA, Fairfax VA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: West Reading PA, Bethlehem PA, Baltimore MD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: West Reading PA, Bethesda MD, Winston-Salem NC,
Sponsor: Stichting European Myeloma Network
Sex: All
Age: 18+
Code: NCT05028348
Phase 3, Recruiting
The Effects of Open Chain Versus Closed Chain Strengthening on Dynamic Valgus During a Step Down Test
for
Dynamic Knee Valgus
Location: Reading PA
Sponsor: Alvernia University
Sex: All
Age: 18 - 65
Code: NCT06348836
Recruiting
A Fruit and Vegetable Prescription Program
for
Diabetes Mellitus, Diabetes Complications
Location: Reading PA
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 18+
Code: NCT06107816
Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
for
Chemotherapy-induced Nausea and Vomiting
Location: Gettysburg PA, Bethesda MD, Massillon OH, Skokie IL,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd
Sex: All
Age: 18+
Code: NCT05199818
Phase 3, Recruiting
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
for
Metastatic Castration-resistant Prostate Cancer
Location: Gettysburg PA, Los Angeles CA
Sponsor: FutureChem
Sex: Male
Age: 18+
Code: NCT05458544
Phase 1, Phase 2, Recruiting
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
for
Genetics of Drug Metabolism
Location: Shippensburg PA, Allentown PA, Newark DE,
Sponsor: Companion Dx Reference Lab, LLC
Sex: All
Age: 18+
Code: NCT02081872
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: Danville PA, Indianapolis IN, Nashville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07631637
Phase 2, Recruiting
M-Vizion™ Macroscopic Radiographic Study
for
Revision Hip Arthroplasty
Location: Danville PA, Boston MA, Lebanon NH, Charlotte NC,
Sponsor: Medacta USA
Sex: All
Age: 21 - 70+
Code: NCT05721859
Recruiting
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Danville PA, New York NY, New Hyde Park NY,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05530343
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)